CN101481702B - Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein - Google Patents
Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein Download PDFInfo
- Publication number
- CN101481702B CN101481702B CN 200910006011 CN200910006011A CN101481702B CN 101481702 B CN101481702 B CN 101481702B CN 200910006011 CN200910006011 CN 200910006011 CN 200910006011 A CN200910006011 A CN 200910006011A CN 101481702 B CN101481702 B CN 101481702B
- Authority
- CN
- China
- Prior art keywords
- virus
- linearizing
- recombinant plasmid
- pbacpakph
- recon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 79
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 34
- 238000000034 method Methods 0.000 title claims abstract description 17
- 239000013598 vector Substances 0.000 title abstract description 13
- 241000700605 Viruses Species 0.000 claims abstract description 43
- 239000013612 plasmid Substances 0.000 claims abstract description 37
- 230000014509 gene expression Effects 0.000 claims abstract description 25
- 238000000746 purification Methods 0.000 claims abstract description 9
- 108010052285 Membrane Proteins Proteins 0.000 claims abstract 2
- 101710182846 Polyhedrin Proteins 0.000 claims description 22
- 230000004927 fusion Effects 0.000 claims description 21
- 102000035195 Peptidases Human genes 0.000 claims description 18
- 108091005804 Peptidases Proteins 0.000 claims description 18
- 241000255789 Bombyx mori Species 0.000 claims description 16
- 241000701447 unidentified baculovirus Species 0.000 claims description 13
- 108091008146 restriction endonucleases Proteins 0.000 claims description 11
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 claims description 10
- 230000008859 change Effects 0.000 claims description 9
- 108020004414 DNA Proteins 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 8
- 230000006801 homologous recombination Effects 0.000 claims description 8
- 238000002744 homologous recombination Methods 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 4
- 238000001042 affinity chromatography Methods 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 4
- 230000008025 crystallization Effects 0.000 claims description 4
- 238000012217 deletion Methods 0.000 claims description 4
- 230000037430 deletion Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 108020005202 Viral DNA Proteins 0.000 claims description 3
- 208000015181 infectious disease Diseases 0.000 claims description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical group 0.000 claims description 2
- 238000000926 separation method Methods 0.000 claims description 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000001976 enzyme digestion Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 230000004853 protein function Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 13
- 238000012546 transfer Methods 0.000 description 13
- 238000004321 preservation Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 230000008878 coupling Effects 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 101150010944 P10 gene Proteins 0.000 description 3
- 108020005038 Terminator Codon Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 101100136147 Arabidopsis thaliana PER10 gene Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 101710085938 Matrix protein Proteins 0.000 description 2
- 101710127721 Membrane protein Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012154 double-distilled water Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 230000029812 viral genome replication Effects 0.000 description 2
- 210000005253 yeast cell Anatomy 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108700020497 Nucleopolyhedrovirus polyhedrin Proteins 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000879 optical micrograph Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000012743 protein tagging Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910006011 CN101481702B (en) | 2009-01-22 | 2009-01-22 | Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910006011 CN101481702B (en) | 2009-01-22 | 2009-01-22 | Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101481702A CN101481702A (en) | 2009-07-15 |
CN101481702B true CN101481702B (en) | 2013-05-01 |
Family
ID=40878992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910006011 Active CN101481702B (en) | 2009-01-22 | 2009-01-22 | Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101481702B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102516369A (en) * | 2011-12-21 | 2012-06-27 | 天津耀宇生物技术有限公司 | Mutant polyhedron and preparation method thereof |
CN102517319A (en) * | 2011-12-27 | 2012-06-27 | 天津耀宇生物技术有限公司 | Method for purifying fusion protein based on bombyx mori baculovirus polyhedron dissolving characteristic |
CN102952807B (en) * | 2012-11-13 | 2015-07-08 | 天津耀宇生物技术有限公司 | Pre-180 bp segments of polynedron gene and application thereof |
CN103834676B (en) * | 2014-02-28 | 2016-12-07 | 中国科学院福建物质结构研究所 | A kind of E. coli secretion expresses plasmid vector and the construction method thereof of foreign protein |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162017A (en) * | 1996-04-08 | 1997-10-15 | 中国农业科学院上海家畜寄生虫病研究所 | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm |
CN1242428A (en) * | 1998-07-17 | 2000-01-26 | 中国科学院上海生物化学研究所 | Gene engineering carrier for recombination salvation linearization silk worm nuclear polyhedral virus |
CN1365390A (en) * | 1999-07-27 | 2002-08-21 | 数位生物技术株式会社 | A human lactoferrin produced by using insect cell and method using the same |
CN1405310A (en) * | 2001-08-15 | 2003-03-26 | 浙江中奇生物药业股份有限公司 | Method for producing medicine using silkworm expressed numan epidermal growth factor |
-
2009
- 2009-01-22 CN CN 200910006011 patent/CN101481702B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1162017A (en) * | 1996-04-08 | 1997-10-15 | 中国农业科学院上海家畜寄生虫病研究所 | Systematic production of recombined Nippon blood-flukes glutathione transferase by using domestic silk-worm |
CN1242428A (en) * | 1998-07-17 | 2000-01-26 | 中国科学院上海生物化学研究所 | Gene engineering carrier for recombination salvation linearization silk worm nuclear polyhedral virus |
CN1365390A (en) * | 1999-07-27 | 2002-08-21 | 数位生物技术株式会社 | A human lactoferrin produced by using insect cell and method using the same |
CN1405310A (en) * | 2001-08-15 | 2003-03-26 | 浙江中奇生物药业股份有限公司 | Method for producing medicine using silkworm expressed numan epidermal growth factor |
Also Published As
Publication number | Publication date |
---|---|
CN101481702A (en) | 2009-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7499896B2 (en) | Virus-free cell line and method for obtaining same | |
KR910009203B1 (en) | Method for rpoducing a recombinant baculovirus expression vector | |
WO2010009614A1 (en) | Secretion expression of antibiotic peptide cad in bacillus subtilis and expression system of recombination bacillus subtilis | |
CN101481702B (en) | Recombinant vector containing polyhedrosis gene, and method for expressing and purifying protein | |
WO1989001038A1 (en) | PRODUCTION OF BIOLOGICALLY ACTIVE FORMS OF CSF USING A BACULOVIRUS (AcNPV)-INSECT CELL EXPRESSION SYSTEM | |
WO2023221787A1 (en) | Pichia pastoris engineering strain for recombinant type i collagen, construction method therefor and use thereof | |
CN112225814A (en) | Novel coronavirus RBD fusion protein subunit vaccine and preparation method and application thereof | |
EP0397485A1 (en) | Novel baculovirus expression vectors and use thereof in the expression of foreign proteins in insects or insect cells | |
Acharya et al. | Bombyx mori nucleopolyhedrovirus: molecular biology and biotechnological applications for large-scale synthesis of recombinant proteins | |
CN108484750A (en) | 3 interferon mutants of pig λ and its preparation method and application | |
CA2261186A1 (en) | Expression and secretion of heterologous polypeptides from freshwater caulobacter | |
CN101880314B (en) | Bursin-like peptide of gene engineering as well as expression gene and application thereof | |
CN114317571A (en) | Virus-like particle and preparation method and application thereof | |
Chakraborty et al. | Modifying baculovirus expression vectors to produce secreted plant proteins in insect cells | |
CN107254001A (en) | It is a kind of by dog albumin and dog interferon γ fusion protein constituted and preparation method thereof and a kind of canine recombinant long-acting interferon γ | |
Emery | Baculovirus expression vectors: choice of expression vector | |
Shen et al. | Characterization of the Bm61 of the Bombyx mori nucleopolyhedrovirus | |
JP6044974B2 (en) | Recombinant silkworm nuclear polyhedrosis virus vector | |
JP6048959B2 (en) | Production method of lysozyme | |
CN101205535A (en) | A method for making recombinant baculovirus obtain polyhedron coating | |
CN105255945B (en) | A kind of method using silkworm to prepare analgesic polypeptide | |
CN110257396A (en) | A kind of anti-ALV-J chicken lambda interferon and its preparation method and application | |
AU6184900A (en) | A human lactoferrin produced by using an insect cell and method using the same | |
Lihoradova et al. | Biosynthesis of the recombinant middle surface antigen of the human hepatitis B virus in silkworm larvae | |
CN116240182A (en) | Application of luciferase signal peptide, fusion protein containing luciferase signal peptide and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN YAOYU BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHONGQI BIOLOGICAL PHARMACEUTICAL CO., LTD., ZHEJIANG Effective date: 20121023 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 314411 JIAXING, ZHEJIANG PROVINCE TO: 300457 HANGU, TIANJIN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20121023 Address after: 300457 No. 220, Dongting Road, Tianjin economic and Technological Development Zone, 5 floor, experimental building, Tianjin international biological medicine Joint Research Institute, S514 Applicant after: TIANJIN YAOYU BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 314411, No. three Li Li bridge, salt town, Zhejiang, Haining, 52 Applicant before: ZHONGQI BIOLOG PHARMACEUTICAL |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder |
Address after: 300457 intersection of Dongting Road and thirteen Avenue, Binhai New Area Economic and Technological Development Zone, Tianjin, Tianjin International Joint Research Institute of biomedicine, S501 Patentee after: TIANJIN YAOYU BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: 300457 No. 220, Dongting Road, Tianjin economic and Technological Development Zone, 5 floor, experimental building, Tianjin international biological medicine Joint Research Institute, S514 Patentee before: TIANJIN YAOYU BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
CP02 | Change in the address of a patent holder | ||
PP01 | Preservation of patent right |
Effective date of registration: 20191202 Granted publication date: 20130501 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20221202 Granted publication date: 20130501 |
|
PD01 | Discharge of preservation of patent | ||
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20221202 Granted publication date: 20130501 |